ArticleJournal of global health2021
Evaluation of China's public health system response to COVID-19.
Article in Journal of global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- The effect of integration of medical and preventive services on the prevention and control of public health emergencies in China.Frontiers in public health · 2026Article
- Determinants of equitable public health human resource allocation in China: a multidimensional analysis using RIF-I-OLS decomposition.Human resources for health · 2025Article
- Potential of biomarkers of ageing in predicting severity of influenza virus infection and vaccination efficacy.npj aging · 2025Review
- Spatiotemporal dynamics and driving factors of human resources for health in traditional Chinese medicine in China.Scientific reports · 2025Article
- Distance Learning During the COVID-19 Lockdown and Self-Assessed Competency Development Among Radiology Residents in China: Cross-Sectional Survey.JMIR medical education · 2025Article
- Equity and efficiency of public health resource allocation in China.BMC public health · 2025Article
- COVID-19 vaccine hesitancy among the Chinese elderly: A multi-stakeholder qualitative study.Human vaccines & immunotherapeutics · 2024Article
- Advancing China's Disease Control and Prevention System: A Strategic Roadmap for High-Quality Development.China CDC weekly · 2024Article
- Unraveling the relationships among pandemic fear, cyberchondria, and alexithymia after China's exit from the zero-COVID policy: insights from a multi-center network analysis.Frontiers in psychiatry · 2024Article
- Human Resources Allocation of the Centers for Disease Control and Prevention in China.Risk management and healthcare policy · 2024Article
- Evaluation of the impact of the COVID-19 pandemic on health service utilization in China: A study using auto-regressive integrated moving average model.Frontiers in public health · 2023Article
- High prevalence and risk factors of dropout intention among Chinese medical postgraduates.Medical education online · 2022Article
- Reflections on China's primary care response to COVID-19: roles, limitations and implications.Primary health care research & development · 2022Article
- Prevalence and influencing factors of pandemic fatigue among Chinese public in Xi'an city during COVID-19 new normal: a cross-sectional study.Frontiers in public health · 2022Article
- Article
- China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.Frontiers in public health · 2021Article
- Response to the COVID-19 Pandemic: Comparison of Strategies in Six Countries.Frontiers in public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe focus of the study is to assess the advantages and shortcomings of China's public health system in the process of the COVID-19 prevention and to discuss the future reform of China's public health system.
methodsBy searching literature and reports related to the COVID-19 prevention of China, we compared the prevention effectiveness with the prevention policies in the process of the COVID-19 prevention.
resultsChina's public health system can effectively combine national power to maximize the effectiveness of pandemic prevention. It improved the pandemic prevention ability of communities continuously and promoted the fairness of prevention. Traditional Chinese Medicine has also been used in pandemic prevention, which reduces the drug resistance of the virus. At the same time, the combination of the disease diagnosis and the Internet has reduced the spread speed of the pandemic. China's public health system also has some problems in response to the COVID-19, such as the shortage of medical resources, insufficient alerts, the low efficiency of reporting to superior government and the shortage of reward and punishment system for pandemic prevention.
conclusionsChina's practice and efforts of the COVID-19 prevention can provide experience for other countries to improve their public health systems and accelerate the end of the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.